YONGHE MED.GR.DL-0000025 (F:L97) — Market Cap & Net Worth
Market Cap & Net Worth: YONGHE MED.GR.DL-0000025 (L97)
YONGHE MED.GR.DL-0000025 (F:L97) has a market capitalization of $106.95 Million (€91.48 Million) as of May 2, 2026. Listed on the F stock exchange, this Germany-based company holds position #18923 globally and #1748 in its home market, demonstrating a 4.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying YONGHE MED.GR.DL-0000025's stock price €0.22 by its total outstanding shares 499863416 (499.86 Million).
YONGHE MED.GR.DL-0000025 Market Cap History: 2021 to 2026
YONGHE MED.GR.DL-0000025's market capitalization history from 2021 to 2026. Data shows change from $945.14 Million to $126.23 Million (-38.40% CAGR).
YONGHE MED.GR.DL-0000025 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how YONGHE MED.GR.DL-0000025's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of L97 by Market Capitalization
Companies near YONGHE MED.GR.DL-0000025 in the global market cap rankings as of May 2, 2026.
Key companies related to YONGHE MED.GR.DL-0000025 by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #256 globally with a market cap of $96.85 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #962 globally with a market cap of $27.16 Billion USD ( €23.23 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #972 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1292 globally with a market cap of $19.57 Billion USD ( RM77.93 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #256 | HCA Holdings Inc | NYSE:HCA | $96.85 Billion | $433.09 |
| #962 | Fresenius SE & Co. KGaA | XETRA:FRE | $27.16 Billion | €41.25 |
| #972 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1292 | IHH Healthcare Bhd | KLSE:5225 | $19.57 Billion | RM8.82 |
YONGHE MED.GR.DL-0000025 Historical Marketcap From 2021 to 2026
Between 2021 and today, YONGHE MED.GR.DL-0000025's market cap moved from $945.14 Million to $ 126.23 Million, with a yearly change of -38.40%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €126.23 Million | +27.06% |
| 2025 | €99.35 Million | +66.67% |
| 2024 | €59.61 Million | -55.65% |
| 2023 | €134.41 Million | -83.09% |
| 2022 | €794.77 Million | -15.91% |
| 2021 | €945.14 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of YONGHE MED.GR.DL-0000025 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $106.95 Million USD |
| MoneyControl | $106.95 Million USD |
| MarketWatch | $106.95 Million USD |
| marketcap.company | $106.95 Million USD |
| Reuters | $106.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About YONGHE MED.GR.DL-0000025
Yonghe Medical Group Co., Ltd. provides hair-related healthcare services in China. The company offers hair transplant, medical hair care, routine hair restoration, and other ancillary services. It also engages provision of hair research and consulting services; investment and management; and wig business. The company was founded in 2005 and is headquartered in Beijing, China.